Anti-bipolar therapy: Mechanism of action of lithium

Molecular Psychiatry

Volumn 4, Issue 2, 1999, Pages 117-128

  Jope, R S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

AP 1; Bipolar disorder; Cyclic AMP; Glutamate; Inositol; Lithium

Indexed keywords

CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; LITHIUM; NEUROTRANSMITTER; PROTEIN KINASE C; TRANSCRIPTION FACTOR;

CYTOSKELETON; GENE EXPRESSION; HUMAN; MANIC DEPRESSIVE PSYCHOSIS; MOOD; NERVE CELL PLASTICITY; NEUROPROTECTION; PRIORITY JOURNAL; REVIEW; SECOND MESSENGER;

EID: 0032947795     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000494     Document Type: Review

References (150)

1. Sherman WR, Gish BG, Honchar MP, Munsell LY. Effects of lithium on phosphoinositide metabolism in vivo. Fed Proc 1986; 45: 2639-2646.
2. Wood AJ, Goodwin GM. A review of the biochemical and neuro-pharmacological actions of lithium. Psychol Med 1987; 17: 579-600.
3. Mork A, Geisler A, Hollund P. Effects of lithium on second messenger systems in the brain. Pharmacol Toxicol 1992; 71: 4-17.
4. Post RM. Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010.
5. Avissar S, Schreiber G. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders. Biol Psychiatry 1992; 31: 435-459.
6. Gani D, Downes CP, Batty I, Bramham J. Lithium and myo-inositol homeostasis. Biochim Biophys Acta 1993; 1177: 253-269.
7. Duman RS, Heninger GR, Nestler EJ. Adaptations of receptor-coupled signal transduction pathways underlying stress- and drug-induced neural plasticity. J Nerv Ment Dis 1994; 182: 692-700.
8. Price LH, Heninger GR. Lithium in the treatment of mood disorders. New Engl J Med 1994; 331: 591-598.
9. Lachman HM, Papolos DF. A molecular model for bipolar affective disorder. Med Hypoth 1995; 45: 255-264.
10. Manji HK, Lenox RH. Long-term action of lithium: a role for transcriptional and posttranscriptional factors regulated by protein kinase C. Synapse 1994; 16: 11-28.
11. Jope RS, Williams MB. Lithium and brain signal transduction systems. Biochem Pharmacol 1994; 47: 429-441.
12. + in the treatment of bipolar disorder. Trends Neurosci 1995; 18: 344-349.
13. Belmaker RH, Bersudsky Y, Agam G, Levine J, Kofman O. How does lithium work on manic depression? Clinical and psychological correlates of the inositol theory. Annu Rev Med 1996; 47: 47-56.
14. Soares JC, Gershon S. The lithium ion: a foundation for psychopharmacological specificity. Neuropsychopharmacology 1998; 19: 167-182.
15. Jope RS. A bimodal model of the mechanism of action of lithium. Mol Psychiatry 1999; 4: 21-25.
16. 3H]inositol radioactivity and mass of second messenger inositol 1,4,5-trisphosphate in monkey cerebral cortex slices. J Neurochem 1992; 59: 2332-2335.
17. Dixon JF, Los GV, Hokin LE. Lithium stimulates glutamate 'release' and inositol 1,4,5-trisphosphate accumulation via activation of the N-methyl-D-aspartate receptor in monkey and mouse cerebral cortex slices. Proc Natl Acad Sci USA 1994; 91: 8358-8362.
18. Los GV, Artemenko IP, Hokin LE. Time-dependent effects of lithium on the agonist-stimulated accumulation of second messenger inositol 1,4,5-trisphosphate in SH-SY5Y human neuroblastoma cells. Biochem J 1995; 311: 225-232.
19. Dixon JF, Hokin LE. The antibipolar drug valproate mimics lithium in stimulating glutamate release and inositol 1,4,5-trisphosphate accumulation in brain cortex slices but not accumulation of inositol monophosphates and bisphosphates. Proc Natl Acad Sci USA 1997; 94: 4757-4760.
20. Dixon JF, Hokin LE. Lithium acutely inhibits and chronically upregulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proc Natl Acad Sci USA 1998; 95: 8363-8368.
21. Volonte C, Rukenstein A. Lithium chloride promotes short-term survival of PC12 cells after serum and NGF deprivation. Lithium 1993; 4: 211-219.
22. D'Mello SR, Anelli R, Calissano P. Lithium induces apoptosis in immature cerebellar granule cells but promotes survival of mature neurons. Exp Cell Res 1994; 211: 332-338.
23. Volonte C, Ciolti MT, Merlo D. LiCl promotes survival of GABA-ergic neurons from cerebellum and cerebral cortex: LiCl induces survival of GABAergic neurons. Neurosci Lett 1994; 172: 6-10.
24. Li R, Shen Y, El-Mallakh RS. Lithium protects against ouabain-induced cell death. Lithium 1994; 5: 211-216.
25. Inouye M, Yamamura H, Nakano A. Lithium delays the radiation-induced apoptotic process in external granule cells of mouse cerebellum. J Radiat Res 1995; 36: 203-208.
26. Pascual T, Gonzalez, JL. A protective effect of lithium on rat behavior altered by ibotenic acid lesions of the basal forebrain cholinergic system. Brain Res 1995; 695: 289-292.
27. + protection of cerebellar granule neurons switched to non-depolarizing medium. Eur J Pharmacol 1996; 315: 111-114.
28. Nonaka S, Hough CJ, Chuang D-M. Chronic lithium treatment robustly protects neurons in the central nervous system against excitotoxicity by inhibiting N-methyl-D-aspartate receptor-mediated calcium influx. Proc Natl Acad Sci USA 1998; 95: 2642-2647.
29. Nonaka S, Chuang D-M. Neuroprotective effects of lithium on focal cerebral ischemia in rats. Neuroreport 1998; 9: 2081-2084.
30. Nonaka S, Katsube N, Chuang D-M. Lithium protects rat cerebellar granule cells against apoptosis induced by anticonvulsants, phenytoin and carbamazepine. J Pharmacol Exp Ther 1998; 286: 539-547.
31. Sparapani M, Virgili M, Ortali F, Contestabile A. Effects of lithium treatment on ornithine decarboxylase induction and excitotoxic neuropathology in the rat. Brain Res 1997; 765: 164-168.
32. Kabakov AY, Karkanias NB, Lenox RH, Papke RL. Synapse-specific accumulation of lithium in intracellular microdomains: a model for uncoupling coincidence detection in the brain. Synapse 1998; 28: 271-279.
33. Manji HK, Zeng WZ, Huang D, Ikonomov OC, Chen G. A new common transcriptional target for the mood-stabilizing agents lithium and valproic acid. Soc Neurosci Abstr 1997; 23: 2045.
34. Chuang D-M, Chen R-W. Chronic lithium induces p53 downregulation and bcl-2 upregulation in cerebellar neurons: a potential role in neuroprotection against excitotoxicity. Soc Neurosci Abstr 1998; 24: 997.
35. + stimulates ATP-regulaled dopamine uptake in PC12 cells. Neuroscience 1995; 65: 1-4.
36. Dziedzicka-Wasylewska M, Mackowiak M, Figat K, Wedzony K. Adaptive changes in the rat dopaminergic transmission following repeated lithium administration. J Neural Trans 1996; 103: 765-776.
37. Acquas E, Fibiger, HC. Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex. Psychopharmacology 1996; 125: 162-167.
38. Carli M, Morissette M, Hebert C, Di Paolo T, Reader TA. Effects of chronic lithium treatment on central dopamine transporters. Biochem Pharmacol 1997; 54: 391-397.
39. Ormandy GC, Song L, Jope RS. Analysis of the convulsant-potentiating effects of lithium. Exp Neurol 1991; 111: 356-361.
40. Jope RS, Gu X. Seizures increase acetylcholine and choline concentrations in rat brain regions. Neurochem Res 1991; 16: 1219-1226.
41. Bagetta G, Rodino P, Paoletti AM, Arabia A, Massoud R, Nistico G. Systemic administration of lithium chloride and tacrine but not kainic acid augments citrulline content of rat brain. Eur J Pharmacol 1995; 294: 341-433.
42. Motohashi N. GABA receptor alterations after chronic lithium administration. Comparison with carbamazepine and sodium valproate. Prog Neuropsychopharmacol Biol Psychiatry 1992; 16: 571-579.
43. Vargas C, Tannhauser M, Barros HM. Dissimilar effects of lithium and valproic acid on GABA and glutamine concentrations in rat cerebrospinal fluid. Gen Pharmacol 1998; 30: 601-604.
44. Williams NB, Jope RS. Lithium potentiates phosphoinositide-linked 5-HT receptor stimulation in vivo. NeuroReport 1994; 5: 1118-1120.
45. Bourin M, Hascoet M, Colombel M-C, Redrobe JP, Baker GB. Differential effects of clonidine, lithium and quinine in the forced swimming test in mice for antidepressants; possible roles of serotoninergic systems. Eur Neuropsychopharmacol 1996; 6: 231-236.
46. Carli M, Reader TA. Regulation of central serotonin transporters by chronic lithium; an autoradiographic study. Synapse 1997; 27: 83-89.
47. 1A receptors. Neurochem Res 1997; 22: 427-435.
48. Moorman JM, Leslie RA. Paradoxical effects of lithium on serotonergic receptor function: an immunocytochemical, behavioral and autoradiographic study. Neuropharmacology 1998; 37: 357-374.
49. Odagaki Y, Koyama T, Yamashita I. Lithium and serotonergic neural transmission: a review of pharmacological and biochemical aspects in animal studies. Lithium 1992; 3: 95-107.
50. Berridge MJ, Downes CP, Hanley MR. Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands. Biochem J 1982; 206: 587-595.
51. Jenkinson S, Patel N, Nahorski SR, Challiss RAJ. Comparative effect of lithium on the phosphoinositide cycle in rat cerebral cortex, hippocampus, and striatum. J Neurochem 1993; 61: 1082-1090.
52. Gray DW, Challiss RAJ, Nahorski SR. Differential effects of lithium on muscarinic cholinoceptor-stimulated CMP-phosphatidate accumulation in cerebellar granule cells, CHO-M3 cells, and SH-SY5Y neuroblastoma cells. J Neurochem 1994; 63: 1354-1360.
53. Jenkinson S, Nahorski SR, Challiss RAJ. Disruption by lithium of phosphatidylinositol-4,5-bisphosphate supply and inositol-1,4,5-trisphosphate generation in Chinese hamster ovary cells expressing human recombinant m1 muscarinic receptors. Mol Pharmacol 1994; 46: 1138-1148.
54. del Rio E, Shinomura T, van der Kaay J, Nicholls DG, Downes CP. Disruption by lithium of phosphoinositide signalling in cerebellar granule cells in primary culture. J Neurochem 1998; 70: 1662-1669.
55. Batty IH, Currie RA, Downes CP. Evidence for a model of integrated inositol phospholipid pools implies an essential role for lipid transport in the maintenance of receptor-mediated phospholipase C activity in 1321N1 cells. Biochem J 1998; 330: 1069-1077.
56. Willars GB, Nahorski SR, Challiss RA. Differential regulation of muscarinic acetylcholine receptor-sensitive polyphosphoinositide pools and consequences for signaling in human neuroblastoma cells. J Biol Chem 1998; 273: 5037-5046.
57. 31P MRS. Biol Psychiatry 1996; 40: 235-246.
58. Shimon H, Agam G, Belmaker RH, Hyde TM, Kleinman JE. Reduced frontal cortex inositol levels in postmortem brain of suicide victims and patients with bipolar disorder. Am J Psychiatry 1997; 154: 1148-1150.
59. Cohen H, Kotler M, Kaplan Z, Matar MA, Kofman O, Belmaker RH. Inositol has behavioral effects with adaptation after chronic administration. J Neural Trans 1997; 104: 299-305.
60. Patishi Y, Lubrich B, Berger M, Kofman O, van Calker D, Belmaker RH. Differential uptake of myo-inositol in vivo into rat brain areas. Eur Neuropsychopharmacol 1996; 6: 73-75.
61. Lubrich B, Patishi Y, Kofman O, Agam G, Berger M Belmaker RH et al. Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus. Mol Psychiatry 1997; 2: 407-412.
62. Belmaker RH, Agam G, van Calker D, Richards MH, Kofman O. Behavioral reversal of lithium effects by four inositol isomers correlates perfectly with biochemical effects on the PI cycle: depletion by chronic lithium of brain inositol is specific to hypothalamus,+ and inositol levels may be abnormal in postmortem brain from bipolar patients. Neuropsychopharmocology 1998; 19: 220-232.
63. Wolfson M, Hertz E, Belmaker RH, Hertz L. Chronic treatment with lithium and pretreatment with excess inositol reduce inositol pool size in astrocytes by different mechanisms. Brain Res 1998; 787: 34-40.
64. Avissar S, Schreiber G, Danon A, Belmaker RH. Lithium inhibits adrenergic and cholinergic increases in GTP binding in rat cortex, Nature 1988; 331: 440-442.
65. Song L, Jope RS. Chronic: lithium treatment impairs phosphatidylinositol hydrolysis in membranes from rat brain regions. J Neurochem 1992; 58: 2200-2206.
66. Manji HK, Chen G, Shimon H, Hsiao JK, Potter WZ, Belmaker RH. Guanine nucleotide-binding proteins in bipolar affective disorder. Arch Gen Psychiatry 1995; 52: 135-144.
67. Avissar S, Murphy DL, Schreiber G. Magnesium reversal of lithium inhibition of beta-adrenergic and muscarinic receptor coupling to G-proteins. Biochem Pharmacol 1991; 41: 171-175.
68. Whitworth P, Heal DJ, Kendall DA. The effect of acute and chronic: lithium treatment on pilocarpine-stimulated phosphoinositide hydrolysis in mouse brain in vivo. Br J Pharmacol 1990; 101: 39-44.
69. Jope RS, Song L, Kolasa K. Inositol trisphosphate, cyclic AMP and cyclic GMP in rat brain regions after lithium and seizures. Biol Psychiatry 1992; 31: 505-514.
70. Gur E, Lerer B, Newman ME. Acute or chronic lithium does not effect agonist-stimulated inositol trisphosphate formation in rat brain in vivo. Neuroreport 1996; 7: 393-396.
71. J-muscarinic acetylcholine receptors in cultured cerebellar granule cells. Neurochem Int 1993; 22: 395-403.
72. Jope RS, Song L, Li PP, Young LT, Kish SJ, Pacheco MA et al. The phosphoinositide signal transduction system is impaired in bipolar affective disorder brain. J Neurochem 1996; 66: 2402-2409.
73. 2+ response in neutrophils of manic-depressive patients: effect of lithium therapy. Neuropsychobiology 1993; 27: 180-183.
74. 2+ response in neutrophils from patients under chronic lithium therapy. Psychiatry Clin Neurosci 1994; 243: 240-243.
75. 3 rat pituitary cells. Br J Pharmacol 1994; 112: 390-395.
76. 2+ mobilization in rat hippocampal slices. Neurochem Int 1995; 26: 233-238.
77. 2+ uptake into platelets in bipolar affective disorder and controls. Clin Nauropharmacol 1996; 19: 48-51.
78. i in cultured astrocytes by chronic treatment with a therapeutically relevant lithium concentration. Brain Res 1996; 711: 245-248.
79. Wang H-Y, Friedman E. Lithium inhibition of protein kinase C activation-induced serotonin release. Psychopharmacology 1989; 99: 213-218.
80. Casebolt TL, Jope RS. Effects of chronic lithium treatment on protein kinase C and cyclic AMP-dependent protein phosphorylation. Biol Psychiatry 1991; 29: 233-243.
81. Lenox RH, Watson DG, Patel J, Ellis J. Chronic lithium administration alters a prominent PKC substrate in rat hippocampus. Brain Res 1992; 570: 333-340.
82. Li PP, Sibony D, Green MA, Warsh JJ. Lithium modulation of phosphoinositide signaling system in rat cortex: selective effect on phorbol ester binding. J Neurochem 1993; 61: 1722-1730.
83. Friedman E, Wang H-Y, Levinson D, Connell TA, Singh H. Altered protein kinase C activity in Lipolar affective disorder, manic episode. Biol Psychiatry 1993; 33: 520-525.
84. Manji HK, Etcheberrigaray R, Chen G, Olds JL. Lithium decreases membrane-associated protein kinase C in hippocampus: selectivity for the α isozyme. J Neurochem 1993; 61: 2303-2310.
85. Bebchuk JM, Arfken CL, Dolan-Manji S, Murphy J, Manji HK. A preliminary investigation of a protein kinase C inhibitor (tamoxifen) in the treatment of acute mania. Arch Gen Psychiatry 1999; (in press).
86. Watson DG, Lenox RH. Chronic lithium-induced down-regulation of MARCKS in immortalized hippocampal cells: potentiation by muscarinic receptor activation. J Neurochem 1996; 67: 767-777.
87. Glaser M, Wanaski S, Buser CA, Boguslavsky V, Rashidzada W, Morris A et al. Myristoylated alanine-rich C kinase substrate (MARCKS) produces reversible inhibition of phospholipase C by sequestering phosphatidylinositol 4,5-bisphosphate in lateral domains. J Biol Chem 1996; 271: 26187-26193.
88. i in humans. Life Sci 1991; 50: 227-233.
89. Ormandy GC, Jope RS. Pertussis toxin potentiates seizures induced by pilocarpine, kainic acid and N-methyl-D-aspartate. Brain Res 1991; 553: 51-57.
90. i modulation of adenylate cyclase in brain. J Neurochem 1992; 59: 200-205.
91. Odagaki Y, Nishi N, Koyama T. Lack of interfering effects of lithium on receptor/G protein coupling in human platelet and rat brain membranes. Biol Psychiatry 1997; 42: 697-703.
92. Mork A, Geisler A. Effects of chronic lithium treatment on agonist-enhanced extracellular concentrations of cyclic AMP in the dorsal hippocampus of freely moving rats. J Neurochem 1995; 65: 134-139.
93. Carli M, Anand-Srivastava MB, Molina-Holgado E, Dewar KM, Reader TA. Effects of chronic lithium treatment on central dopaminergic receptor systems: G proteins as possible targets. Neurochem Int 1994; 24: 13-22.
94. Nestler EJ, Terwilliger RZ, Duman RS. Regulation of endogenous ADP-ribosylation by acute and chronic lithium in rat brain. J Neurochem 1995; 64: 2319-2324.
95. Young LT, Woods CM. Mood stabilizers have differential effects on endogenous ADP ribosylation in C6 glioma cells. Eur J Pharmacol 1996; 309: 215-218.
96. Guitart X, Nestler EJ. Chronic administration of lithium or other antidepressants increases levels of DARPP-32 in rat frontal cortex. J Neurochem 1992; 59: 1164-1167.
97. Jensen JB, Mork A. Altered protein phosphorylation in the rat brain following chronic lithium and carbamazepine treatments. Eur Neuropsychapharmacol 1997; 7: 173-179.
98. Zanardi R, Racagni G, Smeraldi E, Perez E. Differential effects of lithium on platelet protein phosphorylation in bipolar patients and healthy subjects. Psychopharmacology 1997; 129: 44-47.
99. Mori S, Zanardi R, Popoli M, Smeraldi E, Racagni G, Perez J. Inhibitory effect of lithium on cAMP dependent phosphorylation system. Life Sci 1996; 59: 99-104.
100. Mori S, Tardito D, Dorigo A, Zanardi R, Smeraldi E, Racagni G et al. Effects of lithium on cAMP-dependent protein kinase in rat brain. Neuropsychopharmacology 1998; 19: 233-240.
101. Klein PS, Melton DA. A molecular mechanism for the effect of lithium on development. Proc Natl Acad Sci USA 1996; 93: 8455-8459.
102. Horn RS, Walaas O, Walaas E. The influence of sodium, potassium and lithium on the response of glycogen synthetase I to insulin and epinephrine in the isolated rat diaphragm. Biochim Biophys Acta 1973; 313: 296-309.
103. Stambolic V, Ruel L, Woodgett JR. Lithium inhibits glycogen synthase kinase-3 activity and mimics Wingless signaling in intact cells. Current Biol 1996; 6: 1664-1668.
104. Hong M, Chen DCR, Klein PS, Lee VMY. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J Biol Chem 1997; 272: 25326-25332.
105. Munoz-Montano JR, Moreno FJ, Avila J, Diaz-Nido J. Lithium inhibits Alzheimer's disease-like tau protein phosphorylation in neurons. FEBS Lett 1997; 411: 183-188.
106. Zheng-Fischhofer Q, Biernet J, Mandelkow E-M, Illenberger S, Godemann R, Mandelkow E. Sequential phosphorylation of tau by glycogen synthase kinase-3β and protein kinase A at thr212 and ser214 generates the Alzheimer-specific epitope of antibody AT100 and requires a paired-helical-filament-like conformation. Eur J Biochem 1998; 252: 542-552.
107. Xie H, Litersky JM, Hartigan JA, Jope RS, Johnson GVW. The inter-relationship between selective tau phosphorylation and microlubule association. Brain Res 1998; 798: 173-183.
108. Lovestone S, Hartley CL, Pearce J, Anderton BH. Phosphorylation of tau by glycogen synthase kinase-3β in intact mammalian cells: the effects on the organization and stability of microtubules. Neuroscience 1996; 73: 1145-1157.
109. Lucas FR, Gould RG, Gordon-Weeks PR, Salinas PC. Inhibition of GSK-3β leading to the loss of phosphorylated MAP-1B is an early event in axonal remodeling induced by WNT-7a or lithium. J Cell Sci 1998; 111: 1351-1361.
110. Garcia-Perez J, Avila J, Diaz-Nido J. Implication of cyclin-dependent kinases and glycogen synthase kinase 3 in the phosphorylation of microtubule-associated protein 1B in developing neuronal cells. J Neurosci Res 1998; 52: 445-452.
111. Harvey BH, Carstens ME, Taljaard JJF. Evidence that lithium induces a glutamatergic, nitric oxide-mediated response in rat brain. Neurochem Res 1994; 19: 469-474.
112. Shintani F, Kanba S, Nakaki T, Nakamura R, Sato K, Yagi G et al. Inhibition by lithium of cyclic GMP formation without inhibition of nitric oxide generation in the mouse neuroblastoma cell (N1E-115). Neuropsychopharmacology 1994; 11: 119-124.
113. Bagetta G, Corasaniti MT, Melino G, Paoletti AM, Finazzi-Agro, Nistico G. Lithium and tacrine increase the expression of nitric oxide synthase mRNA in the hippocampus of rat. Biochem Biophys Res Commun 1993; 197: 1132-1139.
114. Feinstein DL. Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chloride. J Neurochem 1998; 71: 883-886.
115. Chang MCJ, Grange E, Rabin O, Bell JM, Allen DD, Rapoport SI. Lithium decreases turnover of arachidunate in several brain phospholipids. Neurosci Lett 1996; 220; 171-174.
116. 2 activity. Neurochem Res 1998; 23: 887-892.
117. Arenander AT, de Vellis J, Herschman HR. Induction of c-fos and TIS genes in cultured rat astrocytes by neurotransmitters. J Neurosci Res 1989; 24: 107-114.
118. Kalasapudi VD, Sheftel G, Divish MM, Papolos DF, Lachman HM. Lithium augments fos protooncugene expression in PC12 pheochromocytoma cells: implications for therapeutic action. Brain Res 1990; 521: 47-54.
119. Divish MM, Sheftel G, Boyle A, Kalasapudi VD, Papolos DF, Lachman HM. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action. J Neurosci Res 1991; 28: 40-48.
120. Weiner ED, Kalasapudi VD, Papolos DF, Lachman HM. Lithium augments pilocarpine-induced fos gene expression in rat brain. Brain Res 1991; 553: 117-122.
121. Williams MB, Jope RS. Distinctive rat brain immediate early gene responses to seizures induced by lithium plus pilocarpine. Mol Brain Res 1994; 25: 80-89.
122. Mathe AA, Miller JC, Stenfors C. Chronic dietary lithium inhibits basal c-fos mRNA expression in rat brain. Prog Neuropsychopharmacol Biol Psychiatry 1995; 19: 1177-1187.
123. Harada H, Sugiyama T, Suketa Y. Characterization of inhibition by chronic lithium treatment with lithium ion on nerve growth factor-induced neuronal differentiation of rat PC12 pheochromocytoma cells. J Toxicol Environ Health 1996; 49: 197-206.
124. Miller JC, Mathe AA. Basal and stimulated c-fos mRNA expression in the rat brain: effect of chronic dietary lithium. Nourapsychopharmacology 1997; 16: 408-418.
125. Unlap MT, Jope RS. Lithium attenuates nerve growth factor-induced activation of AP-1 DNA binding activity in PC12 cells. Neuropsychopharmacology 1997; 17: 12-17.
126. Ozaki N, Chuang D-M. Lithium increases transcription factor binding to AP-1 and cyclic AMP-responsive element in cultured neurons and rat brain. J Neurochem 1997; 69: 2336-2344.
127. Namima M, Sugihara K, Okamoto K. Lithium inhibits the reverse tolerance and the c-Fos expression induced by methamphetamine in mice. Brain Res 1998; 782: 83-90.
128. Asghari V, Wang JF, Reiach JS, Young LT. Differential effects of mood stabilizers on Fos/Jun proteins and AP-1 DNA binding activity in human neuroblastoma SH-SY5Y cells. Mol Brain Res 1998; 58: 95-102.
129. Williams MB, Jope RS. Circadian variation in rat brain AP-1 DNA binding activity after cholinergic stimulation: modulation by lithium. Psychopharmacology 1995; 122: 363-368.
130. Jope RS, Song L. AP-1 and NF-KB stimulated by carbachol in human neuroblastoma SH-SY5Y cells are differentially sensitive to inhibition by lithium. Mol Brain Res 1997; 50: 171-180.
131. Yuan P-X, Chen G, Huang L-D, Manji HK. Lithium stimulates gene expression through the AP-1 transcription factor pathway. Mol Brain Res 1998; 58: 225-230.
132. Wang JF, Asghari V, Rockel C, Young LT. Cyclic AMP responsive element binding protein phosphorylation and DNA binding is decreased by chronic lithium but not valproate treatment of SH-SY5Y neuroblastoma cells. Neuroscience 1999; (in press).
133. McGowan S, Eastwood SL, Mead A, Burnet PWJ, Smith C, Flanigan TP et al. Hippocampal and cortical G protein Gsα, Goα, Gi2α mRNA expression after electroconvulsive shock or lithium treatment. Eur J Pharmacol 1996; 306: 249-255.
134. Dwivedi Y, Pandey GN. Effects of subchronic administration of antidepressants and anxiolytics on levels of the α subunits of G proteins in the rat brain. J Neural Trans 1997; 104: 747-760.
135. Jakobsen SN, Wiborg O. Selective effects of long-term lithium and carbamazepine administration on G-protein subunit expression in rat brain. Brain Res 1998; 780: 46-55.
136. Rocha E, Rodnight R. Chronic administration of lithium chloride increases immunodetectable glial fibrillary acidic protein in the rat hippocampus. J Neurochem 1994; 63: 1582-1584.
137. Gilad GM, Gilad VH. Brain polyamine stress response: recurrence after repetitive stressor and inhibition by lithium. J Neurochem 1996; 67: 1992-1996.
138. Bullock BP, McNeil GP, Dobner PR. Synergistic induction of neurotensin gene transcription in PC12 cells parallels changes in AP-1 activity. Mol Brain Res 1994; 27: 232-242.
139. Presse F, Cardona B, Borsu L, Nahon J-L. Lithium increases melanin-concentrating hormone mRNA stability and inhibits tyrosine hydroxylase gene expression in PC12 cells. Mol Brain Res 1997; 52: 270-283.
140. Chen G, Yuan P-X, Jiang Y-M, Huang L-D, Manji HK, Lithium increases tyrosine hydroxylase levels both in vivo and in vitro. J Neurochem 1998; 70: 1768-1771.
141. Zachrisson O, Mathe AA, Stenfors C, Lindefurs N. Region-specific effects of chronic lithium administration on neuropeptide Y and somatostatin mRNA expression in the rat brain. Neurosci Lett 1995; 194: 89-92.
142. Zachrisson O, Mathe AA, Lindefors N. Effects of chronic lithium and electroconvulsive stimuli on cholecystokinin mRNA expression in the rat brain. Mol Brain Res 1996; 43: 347-350.
143. Wang JF, Young LT. Differential display PCR reveals increased expression of 2′,3′ cyclic nucleotide 3′-phosphodiesterase by lithium. FEBS Lett 1996; 386: 225-229.
144. El-Mallakh RS, Wyatt RJ. The Na, K-ATPase hypothesis for bipolar disorder. Biol Psychiatry 1995; 37: 235-244.
145. Baumgartner A, von Stuckrad M, Muller-Oerlinghausen B, Graf K-J, Kurten 1. The hypothalamic-pituitary-thyroid axis in patients maintained on lithium prophylaxis for years: high triiodothyronine serum concentrations are correlated to the prophylactic efficacy. J Affect Dis 1995; 34: 211-218.
146. 3) binding to nuclei from rat cerebral hemispheres. Biol Psychiatry 1995; 37: 106-111.
147. Kallner G, Petterson KG. Renal, thyroid and parathyroid function during lithium treatment: laboratory tests in 207 people treated for 1-30 years. Acta Psychiatr Scand 1995; 91: 48-51.
148. Hafen T, Wollnik F. Effect of lithium carbonate on activity level and circadian period in different strains of rats. Pharmarol Biochem Behavior 1994; 49: 975-983.
149. Antelman SM, Caggiula AR, Kucinski BJ, Fowler H, Gershon S, Edwards DJ et al. The effects of lithium on a potential cycling model of bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 1998; 22: 495-510.
150. Kucinski BJ, Antelman SM, Caggiula AR, Fowler H, Gershon S, Edwards DJ et al. Oscillatory effects of repeated morphine on shock-induced hypoalgesia and beta-endorphin. Synapse 1998; 30: 30-37.